Modern approaches to the diagnosis and treatment of Dravet syndrome in the Russian Federation. (Literature review and resolution of the Expert Council)
Authors:
- V.I. GuzevaVGV.I. Guzeva
- S.I. KutsevSKS.I. Kutsev
- A.S. PetrukhinAPA.S. Petrukhin
- S.O. AyvazyanSAS.O. Ayvazyan
- E.D. BelousovaEBE.D. Belousova
- S.G. BurdSBS.G. Burd
- I.V. VolkovIVI.V. Volkov
- O.V. GlobaOGO.V. Globa
- M.YU. DorofeevaMDM.YU. Dorofeeva
- N.A. ErmolenkoNEN.A. Ermolenko
- E.A. MorozovaEME.A. Morozova
- O.A. RakhmaninaORO.A. Rakhmanina
- 6 October 2025
- journal article
- review article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (9) , 103-116
Abstract
Dravet syndrome (DS) is a rare genetic disorder with onset at 1 year of age, one of the most severe forms of epilepsy, which is characterized by a high frequency and severity of seizures, impaired psychoneurological development, disability and high mortality. Timely diagnosis and treatment can significantly alleviate the course of DS and improve the quality of life of patients and their families. Currently, there is an urgent need to increase awareness of pediatric neurologists and primary care physicians about the diagnostic criteria for the timely detection of patients with DS, referral to an epileptologist to confirm the diagnosis and prescribe the necessary therapy. The provisions of the Expert Council’s resolution, which took place on March 14, 2025, are presented.Keywords
This publication has 45 references indexed in Scilit:
- Additional Results from Two Randomized, Placebo-Controlled Trials of Stiripentol in Dravet Syndrome Highlight a Rapid Antiseizure Efficacy with Longer Seizure-Free PeriodsNeurology and Therapy, 2024
- An Update on Stiripentol Mechanisms of Action: A Narrative ReviewAdvances in Therapy, 2024
- Dravet syndrome: A systematic literature review of the illness burdenEpilepsia Open, 2023
- Efficacy and Safety of Long-Term Treatment with Stiripentol in Children and Adults with Drug-Resistant Epilepsies: A Retrospective Cohort Study of 196 PatientsDrugs - Real World Outcomes, 2022
- Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in EuropeEpilepsia Open, 2021
- Long-term safety and effectiveness of stiripentol in patients with Dravet syndrome: Interim report of a post-marketing surveillance study in JapanEpilepsy Research, 2021
- Mortality in Dravet syndromeEpilepsy Research, 2016
- Neuroprotective activity of stiripentol with a possible involvement of voltage‐dependent calcium and sodium channelsJournal of Neuroscience Research, 2015
- Epileptic Encephalopathies: New Genes and New PathwaysNeurotherapeutics, 2014
- Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: Additional supportive evidenceEpilepsy Research, 2014